And you expect the shorts to give up so easily? The buyers know that the shorts are going to try to take this down today and will wait before going in heavily today. I would expect us to see about $2.50/share early before the heavy buying comes back in. JMO
Bill
Bill
Recent NVAX News
- Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development • PR Newswire (US) • 03/30/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 10:13:36 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/09/2026 10:12:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:04:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:03:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:02:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:01:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:00:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:37:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:35:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:34:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:33:22 AM
- Novavax to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/26/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:02:10 PM
- Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights • PR Newswire (US) • 02/26/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 12:33:51 PM
- Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 • PR Newswire (US) • 02/19/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 12:57:59 AM
- Novavax shares gain after Matrix-M adjuvant licensing deal with Pfizer • IH Market News • 01/20/2026 02:48:06 PM
- Novavax Announces Entering into a License Agreement with Pfizer • PR Newswire (US) • 01/20/2026 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 11:59:39 AM
